NATH BIOGENES (INDIA)
Back to Balance Sheet
|
NATH BIOGENES (INDIA) Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2013 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | - | - | - | - | ₹-0.90 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of NATH BIOGENES (INDIA) ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | - |
| Mar2024 | - |
| Mar2023 | - |
| Mar2022 | - |
| Mar2013 | ₹-0.90 Cr |
How is Deferred Tax Assets / Liabilities of NATH BIOGENES (INDIA) Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | - | 0 | |
| Mar2024 | - | 0 | |
| Mar2023 | - | 0 | |
| Mar2022 | - | 100.00 | |
| Mar2013 | ₹-0.90 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of NATH BIOGENES (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NATH BIOGENES (INDIA) | ₹285.2 Cr | -1.9% | -3.9% | -11.5% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹3,725.5 Cr | -2.9% | -9.3% | -38.6% | Stock Analytics | |
| VENKYS (INDIA) | ₹2,386.6 Cr | 1% | 10.6% | 14.6% | Stock Analytics | |
| AVT NATURAL PRODUCTS | ₹1,404.2 Cr | 0.7% | 30.2% | 20.3% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹957.9 Cr | 2.9% | -0.8% | NA | Stock Analytics | |
| MANGALAM GLOBAL ENTERPRISE | ₹520.0 Cr | 9% | 8.1% | -1.7% | Stock Analytics | |
NATH BIOGENES (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NATH BIOGENES (INDIA) | -1.9% |
-3.9% |
-11.5% |
| SENSEX | -2.4% |
-4.8% |
-7.2% |
You may also like the below Video Courses